M&A: Theragenics and Juniper make it official
Theragenics gives PE firm Juniper another week of exclusivity in buyout bid
It appears that Theragenics (NYSE:TGX) and Juniper Investment Co. need a little more time to hash out the details of an acquisition that has been valued at more than $70 million.
Theragenics soars on private equity buyout offer
Theragenics (NYSE:TGX) said a private equity firm, Juniper Investment Co., offered to pay up to roughly $71 million for the medical device company, sending its shares to a 52-week high today on Wall Street.
